Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Pure Sertoli cell tumor of the right ovary managed with fertility-sparing surgery: a case report.

Created on 13 Jul 2026

Authors

Yohannis Derbew Molla, Suleiman Ayalew Belay, Abebaw Muhabaw Zegeye, Samuel Addisu Abera, Endeshaw Asaye Kindie, Getachew Shiferaw Yigezaw

Published in

Oxford medical case reports. Volume 2026. Issue 7. Pages omag131. Epub Jul 12, 2026.

Abstract

Sertoli cell tumors (SCTs) of the ovary are rare sex cord-stromal neoplasms. We describe a 37-year-old Ethiopian woman (G2P2) with six months of progressive lower abdominal pain but no virilization. Ultrasound revealed a solid 11 cm right adnexal mass. Hormonal profile was normal. An open fertility-sparing right salpingo-oophorectomy was performed. Histopathology confirmed a FIGO Stage IA well-differentiated pure SCT. Postoperative surveillance was conducted via clinical pelvic examinations and abdominal/pelvic ultrasounds every three months. At 12-month follow-up, there was no recurrence. This case highlights that SCTs may be hormonally inactive; histopathologic evaluation remains decisive, and fertility-preserving surgery is a safe option in early-stage lesions.

PMID:
42438668
Bibliographic data and abstract were imported from PubMed on 13 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement